Boothbay Fund Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Boothbay Fund Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-617,072	Closed	-$7.62M	–	1906
2024 Q4	$7.62M	Buy	+617,072	New	+$7.07M	0.19%	156
2024 Q3	–	Sell	-142,675	Closed	-$1.02M	–	2005
2024 Q2	$1.02M	Sell	142,675 -242,633	-63%	-$1.86M	0.02%	713
2024 Q1	$2.58M	Buy	385,308 +98,519	+34%	+$678K	0.05%	420
2023 Q4	$1.86M	Buy	286,789 +233,286	+436%	+$1.5M	0.05%	520
2023 Q3	$505K	Buy	53,503 +16,507	+45%	+$199K	0.01%	1032
2023 Q2	$517K	Buy	+36,996	New	+$631K	0.01%	1082

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boothbay Fund Management's CDMO Position: Q1 2025 in Review

Boothbay Fund Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 617,072 shares — an estimated $7.62M sold.

Boothbay Fund Management first reported a position in CDMO in Q2 2023 and held it in 6 quarters. The position peaked at $7.62M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

Boothbay Fund Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Boothbay Fund Management sold 617,072 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $7.62M.
Boothbay Fund Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
Boothbay Fund Management's Avid Bioservices, Inc. Common Stock position peaked at $7.62M in Q4 2024.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.